Solving the Problem of Insolubility: Part I

As drug discovery evolves, the complexity of new drug molecules necessitates advanced delivery technologies. Austin Px's Elizabeth Hickman and Dave Miller describe the challenges posed by poorly soluble drugs in contemporary pipelines, stemming from methods like AI and structure-based design. With conventional drug delivery methods insufficient for complex compounds, innovative solutions like KinetiSol emerge, enabling absorption without organic solvents or significant thermal degradation. This advancement is crucial, especially for oncology treatments targeting previously unreachable pathways.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

I have read and understand the Privacy Notice*

Subscribe